- Home
- FBGL vs CHRO Comparison
FBGL vs CHRO Comparison
Compare FBGL & CHRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBGL
- CHRO
- Stock Information
- Founded
- FBGL 1996
- CHRO 2002
- Country
- FBGL Singapore
- CHRO United States
- Employees
- FBGL N/A
- CHRO N/A
- Industry
- FBGL Miscellaneous manufacturing industries
- CHRO
- Sector
- FBGL Consumer Discretionary
- CHRO
- Exchange
- FBGL Nasdaq
- CHRO Nasdaq
- Market Cap
- FBGL 7.8M
- CHRO 8.4M
- IPO Year
- FBGL 2025
- CHRO 2024
- Fundamental
- Price
- FBGL $0.66
- CHRO $1.14
- Analyst Decision
- FBGL
- CHRO Strong Buy
- Analyst Count
- FBGL 0
- CHRO 1
- Target Price
- FBGL N/A
- CHRO N/A
- AVG Volume (30 Days)
- FBGL 143.2K
- CHRO 83.2K
- Earning Date
- FBGL 01-01-0001
- CHRO 05-13-2025
- Dividend Yield
- FBGL N/A
- CHRO N/A
- EPS Growth
- FBGL N/A
- CHRO N/A
- EPS
- FBGL N/A
- CHRO N/A
- Revenue
- FBGL $10,146,582.00
- CHRO N/A
- Revenue This Year
- FBGL N/A
- CHRO N/A
- Revenue Next Year
- FBGL N/A
- CHRO N/A
- P/E Ratio
- FBGL N/A
- CHRO N/A
- Revenue Growth
- FBGL N/A
- CHRO N/A
- 52 Week Low
- FBGL $0.44
- CHRO $0.45
- 52 Week High
- FBGL $5.45
- CHRO $3.80
- Technical
- Relative Strength Index (RSI)
- FBGL N/A
- CHRO 53.88
- Support Level
- FBGL N/A
- CHRO $0.90
- Resistance Level
- FBGL N/A
- CHRO $1.06
- Average True Range (ATR)
- FBGL 0.00
- CHRO 0.09
- MACD
- FBGL 0.00
- CHRO 0.03
- Stochastic Oscillator
- FBGL 0.00
- CHRO 95.88
About FBGL FBS Global Limited Ordinary Shares
FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial, and industrial building projects. As a green contractor focused on environmentally sound practices, the company aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts and Sales of construction materials.
About CHRO Chromocell Therapeutics Corporation
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic, visceral pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.